top of page

ASGCT 2026: Aurion Biotech is developing an off the shelf cell therapy solution for Corneal endothelial disease, a type of blindness, where only donor transplants are currently available to some

  • May 15
  • 1 min read

Founder, CSO & CEO Arnaud Lacoste describes the treatment, which is derived from one donor and can treat up to 1,000 patients, and comes in a solution containing a rho-kinase inhibitor. It is currently in a U.S. pivotal study.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page